XenTech

XenTech is a science-driven Contract Research Organization (CRO) specialized in preclinical oncology. The company provides expert advisory support in the management of experimental pharmacology projects and is dedicated to accelerating the development of new anti-cancer therapies through preclinical services, including the use of predictive PDX models and the identification of biomarkers and therapeutic targets to facilitate the discovery of novel treatments.